Selected research
Industry Research
Lanji Pills Industry Research Report 2026
Market perspective
The global Lanji Pills market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Lanji Pills is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Lanji Pills is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Lanji Pills is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Lanji Pills include Beijing Tongrentang Pharmaceutical Co., Ltd., Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory, Hebei Kainuo Pharmaceutical Co., Ltd., Henan Jinhongtang Pharmaceutical Co., Ltd., Henan Xinxin Pharmaceutical Co., Ltd., China Resources Sanjiu (Zaozhuang) Pharmaceutical Co., Ltd., Tianjin Pharmaceutical Darentang Group Co., Ltd., Minsheng Pharmaceutical Group Co., Ltd. and Shandong Guangyutang National Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Lanji Pills market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lanji Pills Market by Company
Beijing Tongrentang Pharmaceutical Co., Ltd.
Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory
Hebei Kainuo Pharmaceutical Co., Ltd.
Henan Jinhongtang Pharmaceutical Co., Ltd.
Henan Xinxin Pharmaceutical Co., Ltd.
China Resources Sanjiu (Zaozhuang) Pharmaceutical Co., Ltd.
Tianjin Pharmaceutical Darentang Group Co., Ltd.
Minsheng Pharmaceutical Group Co., Ltd.
Shandong Guangyutang National Pharmaceutical Co., Ltd.
Zuojinming Pharmaceutical Co., Ltd.
Lanji Pills Segment by Type
Modified Lanji Pills
Regular Lanji Pills
Lanji Pills Segment by Application
Hospital
Clinic
Other
Lanji Pills Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lanji Pills market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lanji Pills and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lanji Pills.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lanji Pills manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lanji Pills by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lanji Pills in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Modified Lanji Pills
- Regular Lanji Pills
Applications
- Hospital
- Clinic
- Other
Companies covered
- Beijing Tongrentang Pharmaceutical Co., Ltd.
- Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory
- Hebei Kainuo Pharmaceutical Co., Ltd.
- Henan Jinhongtang Pharmaceutical Co., Ltd.
- Henan Xinxin Pharmaceutical Co., Ltd.
- China Resources Sanjiu (Zaozhuang) Pharmaceutical Co., Ltd.
- Tianjin Pharmaceutical Darentang Group Co., Ltd.
- Minsheng Pharmaceutical Group Co., Ltd.
- Shandong Guangyutang National Pharmaceutical Co., Ltd.
- Zuojinming Pharmaceutical Co., Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Lanji Pills Market Size (2021-2032)
- 2.2.2 Global Lanji Pills Sales (2021-2032)
- 2.2.3 Global Lanji Pills Market Average Price (2021-2032)
- 2.3 Lanji Pills by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Modified Lanji Pills
- 2.3.3 Regular Lanji Pills
- 2.4 Lanji Pills by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lanji Pills Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Lanji Pills Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Lanji Pills Revenue of Manufacturers (2021-2026)
- 3.4 Global Lanji Pills Average Price by Manufacturers (2021-2026)
- 3.5 Global Lanji Pills Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Lanji Pills, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Lanji Pills, Product Type & Application
- 3.8 Global Manufacturers of Lanji Pills, Established Date
- 3.9 Global Lanji Pills Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Beijing Tongrentang Pharmaceutical Co., Ltd.
- 4.1.1 Beijing Tongrentang Pharmaceutical Co., Ltd. Company Information
- 4.1.2 Beijing Tongrentang Pharmaceutical Co., Ltd. Business Overview
- 4.1.3 Beijing Tongrentang Pharmaceutical Co., Ltd. Lanji Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Beijing Tongrentang Pharmaceutical Co., Ltd. Lanji Pills Product Portfolio
- 4.1.5 Beijing Tongrentang Pharmaceutical Co., Ltd. Recent Developments
- 4.2 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory
- 4.2.1 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Company Information
- 4.2.2 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Business Overview
- 4.2.3 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Lanji Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Lanji Pills Product Portfolio
- 4.2.5 Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory Recent Developments
- 4.3 Hebei Kainuo Pharmaceutical Co., Ltd.
- 4.3.1 Hebei Kainuo Pharmaceutical Co., Ltd. Company Information
- 4.3.2 Hebei Kainuo Pharmaceutical Co., Ltd. Business Overview
- 4.3.3 Hebei Kainuo Pharmaceutical Co., Ltd. Lanji Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Hebei Kainuo Pharmaceutical Co., Ltd. Lanji Pills Product Portfolio
- 4.3.5 Hebei Kainuo Pharmaceutical Co., Ltd. Recent Developments
- 4.4 Henan Jinhongtang Pharmaceutical Co., Ltd.
- 4.4.1 Henan Jinhongtang Pharmaceutical Co., Ltd. Company Information
- 4.4.2 Henan Jinhongtang Pharmaceutical Co., Ltd. Business Overview
- 4.4.3 Henan Jinhongtang Pharmaceutical Co., Ltd. Lanji Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Henan Jinhongtang Pharmaceutical Co., Ltd. Lanji Pills Product Portfolio
- 4.4.5 Henan Jinhongtang Pharmaceutical Co., Ltd. Recent Developments
- 4.5 Henan Xinxin Pharmaceutical Co., Ltd.
- 4.5.1 Henan Xinxin Pharmaceutical Co., Ltd. Company Information
- 4.5.2 Henan Xinxin Pharmaceutical Co., Ltd. Business Overview
- 4.5.3 Henan Xinxin Pharmaceutical Co., Ltd. Lanji Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Henan Xinxin Pharmaceutical Co., Ltd. Lanji Pills Product Portfolio
- 4.5.5 Henan Xinxin Pharmaceutical Co., Ltd. Recent Developments
- 4.6 China Resources Sanjiu (Zaozhuang) Pharmaceutical Co., Ltd.
- 4.6.1 China Resources Sanjiu (Zaozhuang) Pharmaceutical Co., Ltd. Company Information
- 4.6.2 China Resources Sanjiu (Zaozhuang) Pharmaceutical Co., Ltd. Business Overview
- 4.6.3 China Resources Sanjiu (Zaozhuang) Pharmaceutical Co., Ltd. Lanji Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 China Resources Sanjiu (Zaozhuang) Pharmaceutical Co., Ltd. Lanji Pills Product Portfolio
- 4.6.5 China Resources Sanjiu (Zaozhuang) Pharmaceutical Co., Ltd. Recent Developments
- 4.7 Tianjin Pharmaceutical Darentang Group Co., Ltd.
- 4.7.1 Tianjin Pharmaceutical Darentang Group Co., Ltd. Company Information
- 4.7.2 Tianjin Pharmaceutical Darentang Group Co., Ltd. Business Overview
- 4.7.3 Tianjin Pharmaceutical Darentang Group Co., Ltd. Lanji Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Tianjin Pharmaceutical Darentang Group Co., Ltd. Lanji Pills Product Portfolio
- 4.7.5 Tianjin Pharmaceutical Darentang Group Co., Ltd. Recent Developments
- 4.8 Minsheng Pharmaceutical Group Co., Ltd.
- 4.8.1 Minsheng Pharmaceutical Group Co., Ltd. Company Information
- 4.8.2 Minsheng Pharmaceutical Group Co., Ltd. Business Overview
- 4.8.3 Minsheng Pharmaceutical Group Co., Ltd. Lanji Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Minsheng Pharmaceutical Group Co., Ltd. Lanji Pills Product Portfolio
- 4.8.5 Minsheng Pharmaceutical Group Co., Ltd. Recent Developments
- 4.9 Shandong Guangyutang National Pharmaceutical Co., Ltd.
- 4.9.1 Shandong Guangyutang National Pharmaceutical Co., Ltd. Company Information
- 4.9.2 Shandong Guangyutang National Pharmaceutical Co., Ltd. Business Overview
- 4.9.3 Shandong Guangyutang National Pharmaceutical Co., Ltd. Lanji Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Shandong Guangyutang National Pharmaceutical Co., Ltd. Lanji Pills Product Portfolio
- 4.9.5 Shandong Guangyutang National Pharmaceutical Co., Ltd. Recent Developments
- 4.10 Zuojinming Pharmaceutical Co., Ltd.
- 4.10.1 Zuojinming Pharmaceutical Co., Ltd. Company Information
- 4.10.2 Zuojinming Pharmaceutical Co., Ltd. Business Overview
- 4.10.3 Zuojinming Pharmaceutical Co., Ltd. Lanji Pills Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Zuojinming Pharmaceutical Co., Ltd. Lanji Pills Product Portfolio
- 4.10.5 Zuojinming Pharmaceutical Co., Ltd. Recent Developments
5 Global Lanji Pills Market Scenario by Region
- 5.1 Global Lanji Pills Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lanji Pills Sales by Region: 2021-2032
- 5.2.1 Global Lanji Pills Sales by Region: 2021-2026
- 5.2.2 Global Lanji Pills Sales by Region: 2027-2032
- 5.3 Global Lanji Pills Revenue by Region: 2021-2032
- 5.3.1 Global Lanji Pills Revenue by Region: 2021-2026
- 5.3.2 Global Lanji Pills Revenue by Region: 2027-2032
- 5.4 North America Lanji Pills Market Facts & Figures by Country
- 5.4.1 North America Lanji Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Lanji Pills Sales by Country (2021-2032)
- 5.4.3 North America Lanji Pills Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Lanji Pills Market Facts & Figures by Country
- 5.5.1 Europe Lanji Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Lanji Pills Sales by Country (2021-2032)
- 5.5.3 Europe Lanji Pills Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Lanji Pills Market Facts & Figures by Country
- 5.6.1 Asia Pacific Lanji Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Lanji Pills Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Lanji Pills Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Lanji Pills Market Facts & Figures by Country
- 5.7.1 South America Lanji Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Lanji Pills Sales by Country (2021-2032)
- 5.7.3 South America Lanji Pills Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Lanji Pills Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Lanji Pills Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Lanji Pills Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Lanji Pills Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Lanji Pills Sales by Type (2021-2032)
- 6.1.1 Global Lanji Pills Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Lanji Pills Sales Market Share by Type (2021-2032)
- 6.2 Global Lanji Pills Revenue by Type (2021-2032)
- 6.2.1 Global Lanji Pills Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Lanji Pills Revenue Market Share by Type (2021-2032)
- 6.3 Global Lanji Pills Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Lanji Pills Sales by Application (2021-2032)
- 7.1.1 Global Lanji Pills Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Lanji Pills Sales Market Share by Application (2021-2032)
- 7.2 Global Lanji Pills Revenue by Application (2021-2032)
- 7.2.1 Global Lanji Pills Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Lanji Pills Revenue Market Share by Application (2021-2032)
- 7.3 Global Lanji Pills Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Lanji Pills Value Chain Analysis
- 8.1.1 Lanji Pills Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Lanji Pills Production Mode & Process
- 8.2 Lanji Pills Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Lanji Pills Distributors
- 8.2.3 Lanji Pills Customers
9 Global Lanji Pills Analyzing Market Dynamics
- 9.1 Lanji Pills Industry Trends
- 9.2 Lanji Pills Industry Drivers
- 9.3 Lanji Pills Industry Opportunities and Challenges
- 9.4 Lanji Pills Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst